Elekta Linear Accelerator
Device
Elekta Limited
Total Payments
$1.5M
Transactions
19
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $50,000 | 1 | 0 |
| 2019 | $396,556 | 5 | 0 |
| 2018 | $413,551 | 6 | 0 |
| 2017 | $688,794 | 7 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 19 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| JOLT Stablemates | Elekta Limited | $550,000 | 0 |
| Intrafraction Imaging | Elekta Limited | $507,018 | 0 |
| Adaptive Radiotherapy Tools | Elekta Limited | $181,875 | 0 |
| MR guided focal SBRT for low and intermediate-risk localized prostate cancer | Elekta Limited | $126,000 | 0 |
| Elekta linac-based intracranial SRS research group | Elekta Limited | $96,640 | 0 |
| Elekta lung SBRT group | Elekta Limited | $82,590 | 0 |
| Pediatric tumor image guidance and consensus recommendations | Elekta Limited | $4,778 | 0 |
Top Doctors Receiving Payments for Elekta Linear Accelerator
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Dallas, TX | $1.5M | 19 |
Ad
Manufacturing Companies
- Elekta Limited $1.5M
Product Information
- Type Device
- Total Payments $1.5M
- Total Doctors 0
- Transactions 19
About Elekta Linear Accelerator
Elekta Linear Accelerator is a device associated with $1.5M in payments to 0 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is Elekta Limited.
Payment data is available from 2017 to 2020. In 2020, $50,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for Elekta Linear Accelerator is "Unspecified" ($1.5M, 100.0% of total).
Elekta Linear Accelerator is associated with 7 research studies, including "JOLT Stablemates" ($550,000).